Correction: HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma
Biomark Res
.
2024 Feb 16;12(1):27.
doi: 10.1186/s40364-024-00574-0.
Authors
Zhipeng Li
1
,
Huaxin Zhou
1
2
,
Zhijia Xia
3
,
Tong Xia
4
,
Gang Du
4
,
Strohmer Dorothee Franziska
3
,
Xiaoming Li
5
,
Xiangyu Zhai
6
,
Bin Jin
7
8
Affiliations
1
Department of Hepatobiliary Surgery, The Second Hospital of Shandong University, Jinan, China.
2
The Second Clinical College of Shandong University, Jinan, China.
3
Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Munich, Germany.
4
Organ Transplant Department, Qilu Hospital of Shandong University, Jinan, China.
5
Department of Hepatobiliary Surgery, The Second Hospital of Shandong University, Jinan, China. l15288840712@163.com.
6
Department of Hepatobiliary Surgery, The Second Hospital of Shandong University, Jinan, China. xiangyuzhai@126.com.
7
Department of Hepatobiliary Surgery, The Second Hospital of Shandong University, Jinan, China. jinbin9449@126.com.
8
Organ Transplant Department, Qilu Hospital of Shandong University, Jinan, China. jinbin9449@126.com.
PMID:
38365852
PMCID:
PMC10874006
DOI:
10.1186/s40364-024-00574-0
No abstract available
Publication types
Published Erratum